Mismanagement of Antibiotics in Neonatal Medicine

A. Sola
{"title":"Mismanagement of Antibiotics in Neonatal Medicine","authors":"A. Sola","doi":"10.33552/gjpnc.2020.02.000532","DOIUrl":null,"url":null,"abstract":"Unreasonable use of antibiotics occurs in about 25-30% of the population. The neonatal period is among the highest group where antibiotic abuse occurs, as high as 40% in some hospitals. This is particularly apparent in newborn intensive care units (NICU), where 70-80% of the admitted infants receive antibiotics. The main motive for this is that clinicians suspect neonatal sepsis very frequently, but only about 3-5% or less of the time infants have blood culture proven sepsis. The neonatal sepsis calculator, described some years ago and validated by several studies, is extremely useful in allowing care givers to assess risk factors and combine them with the clinical evaluation of the newborn to make a more adequate decision and decrease utilization of unnecessary antibiotics. On the other hand, nonspecific inflammatory markers, like C-reactive protein (CRP) and procalcitonin (PCT), are relied upon to make clinical decisions about antibiotic initiation and discontinuation. However, they have very bad specificity for early and late neonatal sepsis, and their sensitivity is not very adequate either. Relying on them in suspicion of neonatal sepsis is a “hazardous waste”. Antibiotic abuse is associated with short- and long-term adverse effects. In preterm infants in NICU, length of hospital stay, bronchopulmonary dysplasia, necrotizing enterocolitis and mortality are increased. In addition to this and to the concomitant increase in health care expenditures, there are long lasting consequences of antibiotic misuse in the neonatal period. They include development of antibiotic resistance, with the emergence of multi resistant organisms, and alterations to the microbiota and microbiome. This has been linked to various disease states later in life, such as abnormal brain development, infections during childhood, asthma, obesity, diabetes, atherosclerosis and autoimmune disorders, among others. The need to apply clinical measures to modify current neonatal practices and improve outcomes has never been more urgent.","PeriodicalId":87261,"journal":{"name":"Global journal of pediatrics & neonatal care","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global journal of pediatrics & neonatal care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33552/gjpnc.2020.02.000532","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Unreasonable use of antibiotics occurs in about 25-30% of the population. The neonatal period is among the highest group where antibiotic abuse occurs, as high as 40% in some hospitals. This is particularly apparent in newborn intensive care units (NICU), where 70-80% of the admitted infants receive antibiotics. The main motive for this is that clinicians suspect neonatal sepsis very frequently, but only about 3-5% or less of the time infants have blood culture proven sepsis. The neonatal sepsis calculator, described some years ago and validated by several studies, is extremely useful in allowing care givers to assess risk factors and combine them with the clinical evaluation of the newborn to make a more adequate decision and decrease utilization of unnecessary antibiotics. On the other hand, nonspecific inflammatory markers, like C-reactive protein (CRP) and procalcitonin (PCT), are relied upon to make clinical decisions about antibiotic initiation and discontinuation. However, they have very bad specificity for early and late neonatal sepsis, and their sensitivity is not very adequate either. Relying on them in suspicion of neonatal sepsis is a “hazardous waste”. Antibiotic abuse is associated with short- and long-term adverse effects. In preterm infants in NICU, length of hospital stay, bronchopulmonary dysplasia, necrotizing enterocolitis and mortality are increased. In addition to this and to the concomitant increase in health care expenditures, there are long lasting consequences of antibiotic misuse in the neonatal period. They include development of antibiotic resistance, with the emergence of multi resistant organisms, and alterations to the microbiota and microbiome. This has been linked to various disease states later in life, such as abnormal brain development, infections during childhood, asthma, obesity, diabetes, atherosclerosis and autoimmune disorders, among others. The need to apply clinical measures to modify current neonatal practices and improve outcomes has never been more urgent.
新生儿医学中抗生素管理不善
抗生素的不合理使用发生在大约25-30%的人口中。新生儿期是抗生素滥用发生率最高的群体之一,在一些医院高达40%。这在新生儿重症监护室(NICU)尤为明显,那里70-80%的入院婴儿接受抗生素治疗。其主要动机是临床医生经常怀疑新生儿败血症,但只有约3-5%或更少的婴儿出现经血液培养证实的败血症。几年前描述并经几项研究验证的新生儿败血症计算器非常有用,可以让护理人员评估风险因素,并将其与新生儿的临床评估相结合,以做出更充分的决定,减少不必要的抗生素的使用。另一方面,非特异性炎症标志物,如C-反应蛋白(CRP)和降钙素原(PCT),被用来决定抗生素的使用和停用。然而,它们对早期和晚期新生儿败血症的特异性非常差,而且它们的敏感性也不是很充分。依赖他们怀疑新生儿败血症是一种“危险废物”。抗生素滥用与短期和长期的不良反应有关。新生儿重症监护室的早产儿住院时间、支气管肺发育不良、坏死性小肠结肠炎和死亡率增加。除此之外,伴随着医疗保健支出的增加,新生儿时期滥用抗生素也会产生长期的后果。其中包括抗生素耐药性的发展,多重耐药性生物的出现,以及微生物群和微生物组的改变。这与晚年的各种疾病状态有关,如大脑发育异常、儿童期感染、哮喘、肥胖、糖尿病、动脉粥样硬化和自身免疫性疾病等。应用临床措施来改变目前的新生儿做法并改善结果的必要性从未像现在这样迫切。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信